Material Claims. There is no litigation, claim, lawsuit, investigation, action or other proceeding pending or, to the knowledge of Credit Parties, threatened before any court, agency, arbitrator or other tribunal which individually or in the aggregate might result in any material adverse change in the financial condition, operations, businesses or prospects of Credit Parties.
Material Claims. Except as set forth in Schedule 5.8, there is no litigation, suit, action, proceeding or claim pending or, to the knowledge of Seller, proposed or threatened against the Company or the Subsidiary that (a) affects the Company, the Subsidiary or the Assets and could, individually or in the aggregate, if pursued or resulting in a judgment against the Company or the Subsidiary, reasonably be expected to have a Material Adverse Effect, or (b) seeks restraint, prohibition, or other injunctive relief in connection with this Agreement or the consummation of the transactions contemplated hereby. Except as set forth in Schedule 5.8, there is no judgment, decree, injunction, order, determination, award, finding or letter of deficiency of any Governmental Authority or arbitrator outstanding with respect to the Agreement or against the Company, the Subsidiary or, to the knowledge of Seller, any of the Assets, except in each case that could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.
Material Claims. Except as set forth in Schedule 5.8, there is no litigation, suit, action, proceeding or claim pending or, to the knowledge of Shareholders or Shareholders’ counsel, any basis therefore or threat thereof against the Companies or Subsidiaries that would be reasonably expected to result in a Material Adverse Effect on the Company, Subsidiaries or Assets. Except as set forth in Schedule 5.8, there is no judgment, decree, injunction, order, determination, award, finding or letter of deficiency of any Governmental Authority or arbitrator outstanding with respect to the Agreement or against the Companies or Subsidiaries or any of the Assets, except for existing tariffs issued by the PUCO.
Material Claims. Except as set forth in Schedule 5.8, there is no litigation, suit, action, proceeding or claim pending or, to the knowledge of RMO or RMO’s counsel, any basis therefore or threat thereof against the Company that would be reasonably expected to result in a Material Adverse Effect on the Company. Except as set forth in Schedule 5.8, there is no judgment, decree, injunction, order, determination, award, finding or letter of deficiency of any Governmental Authority or arbitrator outstanding with respect to the Agreement or against the Company or any of the Assets.
Material Claims. Except as disclosed in the Company Disclosure Statement, as updated, there is no private or governmental suit, claim, action, or proceeding (arbitral or otherwise) pending or threatened against Company, any of Company's Subsidiaries, or any person who may be entitled to indemnification by Company or Company's Subsidiaries involving a monetary claim in excess of $10,000 or a demand for equitable relief, or against any of their directors or officers relating to the performance of their duties in those capacities.
Material Claims. No material claim shall have arisen, of which Seller is aware, that is not adequately covered by insurance policies maintained by Seller, and Seller shall have delivered a certificate to that effect signed by the chief executive officer of Seller and dated as of the Closing Date.
Material Claims. All Silicone Material Claimants are required to submit the supporting documentation for their Claims by the second anniversary of the Effective Date. Thereafter, the Claims Administrator shall determine, based on the settlement option elected by and approved for each Claimant and the number of Silicone Material Claimants, the amount payable for each Claim from the Silicone Material Claimants Fund of $57.5 million (NPV). The Claims Administrator is to allocate the Silicone Material Claimants Fund such that all Silicone Material Claimants who elect the Expedited Payment Option will receive the same amount and Silicone Material Claims under the Disease Payment Option shall receive no more than 40% of the amount paid to Breast Implant Claimants under the equivalent level of the Grid. The payments to be made to Silicone Material Claimants are further subject to dollar-for-dollar reduction or "marshaling" for any payment that the Claimant has received or is eligible to receive from any other breast implant manufacturer, except that Silicone Material Claimants whose breast implants were made by CUI, Mentor or Bioplasty will be deemed to have marshaled all of the assets of those Entities and will be subject to no reduction. In the event funds from the Silicone Material Claimants Fund remain after payment for Allowed Claims as calculated by the Claims Administrator, the Claims Administrator has the discretion to make a supplemental pro rata distribution to holders of Allowed Silicone Material Claims. C.
Material Claims. 35 5.6. Financial Statements Accurate.....................................................35 5.7. No Defaults or Restrictions.......................................................35 5.8.
Material Claims. There is no litigation, claim, lawsuit, investigation, action or other proceeding pending or, to the knowledge of the Guarantors, threatened before any court, agency, arbitrator or other tribunal which individually or in the aggregate could reasonably be expected to result in any material adverse change in the financial condition, operations, businesses or prospects of the Guarantors.
Material Claims. PMAC shall not settle nor compromise any material claim or litigation or, except in the ordinary and usual course of business, modify, amend or terminate any of its material contracts or waive, release or assign any material rights or claim.
